Outcomes of Congenital Zika Disease Depend on Timing of Infection and Maternal-Fetal Interferon Action

Cell Reports

Volumn 21, Issue 6, 2017, Pages 1588-1599

  Chen, Jinling ^a,b   Liang, Yuejin ^b   Yi, Panpan ^b,d   Xu, Lanman ^b,e   Hawkins, Hal K ^b   Rossi, Shannan L ^b,c   Soong, Lynn ^b,c   Cai, Jiyang ^b   Menon, Ramkumar ^b   Sun, Jiaren ^b,c  

^a NANTONG MEDICAL COLLEGE   (China)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

animal model; antiviral; congenital infection; gestational stage; human pregnancy; interferon ; Zika virus

Indexed keywords

ALPHA2 INTERFERON; INTERFERON; INTERLEUKIN 28A; INTERLEUKIN 29; ALPHA INTERFERON; ANTIVIRUS AGENT; INTERFERON-LAMBDA, HUMAN; MX1 PROTEIN, MOUSE; MYXOVIRUS RESISTANCE PROTEIN;

AMNION CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; FETUS; FETUS DEATH; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOTHER FETUS RELATIONSHIP; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PLACENTA DISORDER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TIME; TROPHOBLAST CELL LINE; VIRUS LOAD; ZIKA FEVER; ZIKA VIRUS; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CHLOROCEBUS AETHIOPS; DRUG EFFECT; INTRAUTERINE GROWTH RETARDATION; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PLACENTA; PREGNANCY; UPREGULATION; VERO CELL LINE; VETERINARY; VIROLOGY; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; FEMALE; FETAL GROWTH RETARDATION; FETUS; HUMANS; INTERFERON-ALPHA; INTERFERONS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYXOVIRUS RESISTANCE PROTEINS; PLACENTA; PREGNANCY; SIGNAL TRANSDUCTION; UP-REGULATION; VERO CELLS; VIRUS REPLICATION; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85034087851     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2017.10.059     Document Type: Article

References (54)

1. Andrade, D., Kim, M., Blanco, L.P., Karumanchi, S.A., Koo, G.C., Redecha, P., Kirou, K., Alvarez, A.M., Mulla, M.J., Crow, M.K., et al. Interferon-α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia. Arthritis Rheumatol. 67 (2015), 977–987.
2. Anson-Cartwright, L., Dawson, K., Holmyard, D., Fisher, S.J., Lazzarini, R.A., Cross, J.C., The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat. Genet. 25 (2000), 311–314.
3. Barrows, N.J., Campos, R.K., Powell, S.T., Prasanth, K.R., Schott-Lerner, G., Soto-Acosta, R., Galarza-Muñoz, G., McGrath, E.L., Urrabaz-Garza, R., Gao, J., et al. A screen of FDA-approved drugs for inhibitors of Zika virus infection. Cell Host Microbe 20 (2016), 259–270.
4. Bayer, A., Lennemann, N.J., Ouyang, Y., Bramley, J.C., Morosky, S., Marques, E.T. Jr., Cherry, S., Sadovsky, Y., Coyne, C.B., Type III interferons produced by human placental trophoblasts confer protection against Zika virus infection. Cell Host Microbe 19 (2016), 705–712.
5. Bierne, H., Travier, L., Mahlakõiv, T., Tailleux, L., Subtil, A., Lebreton, A., Paliwal, A., Gicquel, B., Staeheli, P., Lecuit, M., et al. Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta. PLoS One, 7, 2012, e39080.
6. Bolen, C.R., Ding, S., Robek, M.D., Kleinstein, S.H., Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression. Hepatology 59 (2014), 1262–1272.
7. Brasil, P., Pereira, J.P. Jr., Moreira, M.E., Ribeiro Nogueira, R.M., Damasceno, L., Wakimoto, M., Rabello, R.S., Valderramos, S.G., Halai, U.A., Salles, T.S., et al. Zika virus infection in pregnant women in Rio de Janeiro. N. Engl. J. Med. 375 (2016), 2321–2334.
8. Chervenak, F.A., Rosenberg, J., Brightman, R.C., Chitkara, U., Jeanty, P., A prospective study of the accuracy of ultrasound in predicting fetal microcephaly. Obstet. Gynecol. 69 (1987), 908–910.
9. Costello, A., Dua, T., Duran, P., Gülmezoglu, M., Oladapo, O.T., Perea, W., Pires, J., Ramon-Pardo, P., Rollins, N., Saxena, S., Defining the syndrome associated with congenital Zika virus infection. Bull. World Health Organ., 94, 2016 406–406A.
10. Crotta, S., Davidson, S., Mahlakoiv, T., Desmet, C.J., Buckwalter, M.R., Albert, M.L., Staeheli, P., Wack, A., Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog., 9, 2013, e1003773.
11. Cugola, F.R., Fernandes, I.R., Russo, F.B., Freitas, B.C., Dias, J.L.M., Guimarães, K.P., Benazzato, C., Almeida, N., Pignatari, G.C., Romero, S., et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature 534 (2016), 267–271.
12. Dick, G.W., Kitchen, S.F., Haddow, A.J., Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46 (1952), 509–520.
13. Dowall, S.D., Graham, V.A., Rayner, E., Atkinson, B., Hall, G., Watson, R.J., Bosworth, A., Bonney, L.C., Kitchen, S., Hewson, R., A susceptible mouse model for Zika virus infection. PLoS Negl. Trop. Dis., 10, 2016, e0004658.
14. Doyle, S.E., Schreckhise, H., Khuu-Duong, K., Henderson, K., Rosler, R., Storey, H., Yao, L., Liu, H., Barahmand-pour, F., Sivakumar, P., et al. Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology 44 (2006), 896–906.
15. Egli, A., Santer, D.M., O'Shea, D., Tyrrell, D.L., Houghton, M., The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections. Emerg. Microbes Infect., 3, 2014, e51.
16. Faria, N.R., Azevedo, R.D.S.D.S., Kraemer, M.U.G., Souza, R., Cunha, M.S., Hill, S.C., Thézé, J., Bonsall, M.B., Bowden, T.A., Rissanen, I., et al. Zika virus in the Americas: early epidemiological and genetic findings. Science 352 (2016), 345–349.
17. Foy, B.D., Kobylinski, K.C., Chilson Foy, J.L., Blitvich, B.J., Travassos da Rosa, A., Haddow, A.D., Lanciotti, R.S., Tesh, R.B., Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg. Infect. Dis. 17 (2011), 880–882.
18. Gad, H.H., Hamming, O.J., Hartmann, R., The structure of human interferon lambda and what it has taught us. J. Interferon Cytokine Res. 30 (2010), 565–571.
19. Galani, I.E., Koltsida, O., Andreakos, E., Type III interferons (IFNs): emerging master regulators of immunity. Adv. Exp. Med. Biol. 850 (2015), 1–15.
20. Galani, I.E., Triantafyllia, V., Eleminiadou, E.E., Koltsida, O., Stavropoulos, A., Manioudaki, M., Thanos, D., Doyle, S.E., Kotenko, S.V., Thanopoulou, K., et al. Interferon-lambda mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness. Immunity 46 (2017), 875–890.e6.
21. Grant, A., Ponia, S.S., Tripathi, S., Balasubramaniam, V., Miorin, L., Sourisseau, M., Schwarz, M.C., Sánchez-Seco, M.P., Evans, M.J., Best, S.M., et al. Zika virus targets human STAT2 to inhibit type I interferon signaling. Cell Host Microbe 19 (2016), 882–890.
22. Haddow, A.D., Schuh, A.J., Yasuda, C.Y., Kasper, M.R., Heang, V., Huy, R., Guzman, H., Tesh, R.B., Weaver, S.C., Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl. Trop. Dis., 6, 2012, e1477.
23. Haller, O., Staeheli, P., Schwemmle, M., Kochs, G., Mx GTPases: dynamin-like antiviral machines of innate immunity. Trends Microbiol. 23 (2015), 154–163.
24. Hazin, A.N., Poretti, A., Di Cavalcanti Souza Cruz, D., Tenorio, M., van der Linden, A., Pena, L.J., Brito, C., Gil, L.H.V., de Barros Miranda-Filho, D., Marques, E.T., et al., Microcephaly Epidemic Research Group. Computed tomographic findings in microcephaly associated with Zika virus. N. Engl. J. Med. 374 (2016), 2193–2195.
25. Iwasaki, A., Pillai, P.S., Innate immunity to influenza virus infection. Nat. Rev. Immunol. 14 (2014), 315–328.
26. Jie, Z., Liang, Y., Yi, P., Tang, H., Soong, L., Cong, Y., Zhang, K., Sun, J., Retinoic acid regulates immune responses by promoting IL-22 and modulating S100 proteins in viral hepatitis. J. Immunol. 198 (2017), 3448–3460.
27. Johansson, M.A., Mier-y-Teran-Romero, L., Reefhuis, J., Gilboa, S.M., Hills, S.L., Zika and the risk of microcephaly. N. Engl. J. Med. 375 (2016), 1–4.
28. Kumar, A., Hou, S., Airo, A.M., Limonta, D., Mancinelli, V., Branton, W., Power, C., Hobman, T.C., Zika virus inhibits type-I interferon production and downstream signaling. EMBO Rep. 17 (2016), 1766–1775.
29. Lanciotti, R.S., Kosoy, O.L., Laven, J.J., Velez, J.O., Lambert, A.J., Johnson, A.J., Stanfield, S.M., Duffy, M.R., Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis. 14 (2008), 1232–1239.
30. Lazear, H.M., Daniels, B.P., Pinto, A.K., Huang, A.C., Vick, S.C., Doyle, S.E., Gale, M. Jr., Klein, R.S., Diamond, M.S., Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Sci. Transl. Med., 7, 2015, 284ra59.
31. MacMicking, J.D., Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat. Rev. Immunol. 12 (2012), 367–382.
32. Mahlakõiv, T., Hernandez, P., Gronke, K., Diefenbach, A., Staeheli, P., Leukocyte-derived IFN-α/β and epithelial IFN-λ constitute a compartmentalized mucosal defense system that restricts enteric virus infections. PLoS Pathog., 11, 2015, e1004782.
33. McNab, F., Mayer-Barber, K., Sher, A., Wack, A., O'Garra, A., Type I interferons in infectious disease. Nat. Rev. Immunol. 15 (2015), 87–103.
34. Menon, R., Boldogh, I., Urrabaz-Garza, R., Polettini, J., Syed, T.A., Saade, G.R., Papaconstantinou, J., Taylor, R.N., Senescence of primary amniotic cells via oxidative DNA damage. PLoS One, 8, 2013, e83416.
35. Miner, J.J., Cao, B., Govero, J., Smith, A.M., Fernandez, E., Cabrera, O.H., Garber, C., Noll, M., Klein, R.S., Noguchi, K.K., et al. Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165 (2016), 1081–1091.
36. Mordstein, M., Kochs, G., Dumoutier, L., Renauld, J.C., Paludan, S.R., Klucher, K., Staeheli, P., Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog., 4, 2008, e1000151.
37. Mordstein, M., Neugebauer, E., Ditt, V., Jessen, B., Rieger, T., Falcone, V., Sorgeloos, F., Ehl, S., Mayer, D., Kochs, G., et al. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 84 (2010), 5670–5677.
38. Muir, A.J., Shiffman, M.L., Zaman, A., Yoffe, B., de la Torre, A., Flamm, S., Gordon, S.C., Marotta, P., Vierling, J.M., Lopez-Talavera, J.C., et al. Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection. Hepatology 52 (2010), 822–832.
39. Muir, A.J., Arora, S., Everson, G., Flisiak, R., George, J., Ghalib, R., Gordon, S.C., Gray, T., Greenbloom, S., Hassanein, T., et al., EMERGE study group. A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection. J. Hepatol. 61 (2014), 1238–1246.
40. Petersen, L.R., Jamieson, D.J., Honein, M.A., Zika virus. N. Engl. J. Med. 375 (2016), 294–295.
41. Pott, J., Mahlakõiv, T., Mordstein, M., Duerr, C.U., Michiels, T., Stockinger, S., Staeheli, P., Hornef, M.W., IFN-lambda determines the intestinal epithelial antiviral host defense. Proc. Natl. Acad. Sci. USA 108 (2011), 7944–7949.
42. Potter, J.A., Garg, M., Girard, S., Abrahams, V.M., Viral single stranded RNA induces a trophoblast pro-inflammatory and antiviral response in a TLR8-dependent and -independent manner. Biol. Reprod., 92, 2015, 17.
43. Racicot, K., Kwon, J.Y., Aldo, P., Abrahams, V., El-Guindy, A., Romero, R., Mor, G., Type I interferon regulates the placental inflammatory response to bacteria and is targeted by virus: mechanism of polymicrobial infection-induced preterm birth. Am. J. Reprod. Immunol. 75 (2016), 451–460.
44. Rossant, J., Cross, J.C., Placental development: lessons from mouse mutants. Nat. Rev. Genet. 2 (2001), 538–548.
45. Rossi, S.L., Tesh, R.B., Azar, S.R., Muruato, A.E., Hanley, K.A., Auguste, A.J., Langsjoen, R.M., Paessler, S., Vasilakis, N., Weaver, S.C., Characterization of a novel murine model to study Zika virus. Am. J. Trop. Med. Hyg. 94 (2016), 1362–1369.
46. Schneider, W.M., Chevillotte, M.D., Rice, C.M., Interferon-stimulated genes: a complex web of host defenses. Annu. Rev. Immunol. 32 (2014), 513–545.
47. Schoggins, J.W., Rice, C.M., Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1 (2011), 519–525.
48. Staples, J.E., Dziuban, E.J., Fischer, M., Cragan, J.D., Rasmussen, S.A., Cannon, M.J., Frey, M.T., Renquist, C.M., Lanciotti, R.S., Muñoz, J.L., et al. Interim guidelines for the evaluation and testing of infants with possible congenital Zika virus infection - United States, 2016. MMWR Morb. Mortal. Wkly. Rep. 65 (2016), 63–67.
49. Tabata, T., Petitt, M., Puerta-Guardo, H., Michlmayr, D., Wang, C., Fang-Hoover, J., Harris, E., Pereira, L., Zika virus targets different primary human placental cells, suggesting two routes for vertical transmission. Cell Host Microbe 20 (2016), 155–166.
50. Tscherning-Casper, C., Papadogiannakis, N., Anvret, M., Stolpe, L., Lindgren, S., Bohlin, A.B., Albert, J., Fenyö, E.M., The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy. J. Virol. 73 (1999), 9673–9678.
51. Villenave, R., Broadbent, L., Douglas, I., Lyons, J.D., Coyle, P.V., Teng, M.N., Tripp, R.A., Heaney, L.G., Shields, M.D., Power, U.F., Induction and antagonism of antiviral responses in respiratory syncytial virus-infected pediatric airway epithelium. J. Virol. 89 (2015), 12309–12318.
52. Wang, L., Valderramos, S.G., Wu, A., Ouyang, S., Li, C., Brasil, P., Bonaldo, M., Coates, T., Nielsen-Saines, K., Jiang, T., et al. From mosquitos to humans: genetic evolution of Zika virus. Cell Host Microbe 19 (2016), 561–565.
53. Yockey, L.J., Varela, L., Rakib, T., Khoury-Hanold, W., Fink, S.L., Stutz, B., Szigeti-Buck, K., Van den Pol, A., Lindenbach, B.D., Horvath, T.L., et al. Vaginal exposure to Zika virus during pregnancy leads to fetal brain infection. Cell 166 (2016), 1247–1256.e4.
54. Zhang, D., Wlodawer, A., Lubkowski, J., Crystal structure of a complex of the intracellular domain of interferon λ receptor 1 (IFNLR1) and the FERM/SH2 domains of human JAK1. J. Mol. Biol. 428 (2016), 4651–4668.